These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 36270348)
1. Dominance status is associated with a variation in cannabinoid receptor 1 expression and amphetamine reward. Migliaro M; Sánchez-Zavaleta R; Soto-Tinoco E; Ruiz-Contreras AE; Méndez-Díaz M; Herrera-Solís A; Pérez de la Mora M; Prospéro-García OE Pharmacol Biochem Behav; 2022 Nov; 221():173483. PubMed ID: 36270348 [TBL] [Abstract][Full Text] [Related]
2. Chloramphenicol decreases CB1 receptor expression in the nucleus accumbens and prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats. Amancio-Belmont O; Pérez-Vázquez D; Ruiz-Contreras AE; Pérez de la Mora M; Rueda-Orozco PE; Méndez-Díaz M; Prospero-Garcia OE Pharmacol Biochem Behav; 2017 Aug; 159():1-5. PubMed ID: 28642068 [TBL] [Abstract][Full Text] [Related]
3. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats. Tan SE Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625 [TBL] [Abstract][Full Text] [Related]
4. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. Sellings LH; Clarke PB J Neurosci; 2003 Jul; 23(15):6295-303. PubMed ID: 12867514 [TBL] [Abstract][Full Text] [Related]
5. Nucleus accumbens NMDA receptor activation regulates amphetamine cross-sensitization and deltaFosB expression following sexual experience in male rats. Beloate LN; Weems PW; Casey GR; Webb IC; Coolen LM Neuropharmacology; 2016 Feb; 101():154-64. PubMed ID: 26391065 [TBL] [Abstract][Full Text] [Related]
6. mGluR5 activation in the nucleus accumbens is not essential for sexual behavior or cross-sensitization of amphetamine responses by sexual experience. Pitchers KK; Di Sebastiano AR; Coolen LM Neuropharmacology; 2016 Aug; 107():122-130. PubMed ID: 26946431 [TBL] [Abstract][Full Text] [Related]
7. Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors. Ramiro-Fuentes S; Ortiz O; Moratalla R; Fernandez-Espejo E Neuroscience; 2010 May; 167(2):205-15. PubMed ID: 20167255 [TBL] [Abstract][Full Text] [Related]
8. Medial prefrontal cortex inactivation attenuates the diurnal rhythm in amphetamine reward. Baltazar RM; Coolen LM; Webb IC Neuroscience; 2014 Jan; 258():204-10. PubMed ID: 24239716 [TBL] [Abstract][Full Text] [Related]
9. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens. Ahmad T; Sun N; Lyons D; Laviolette SR Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434 [TBL] [Abstract][Full Text] [Related]
10. Opposed cannabinoid 1 receptor (CB1R) expression in the prefrontal cortex vs. nucleus accumbens is associated with alcohol consumption in male rats. Amancio-Belmont O; Becerril Meléndez AL; Ruiz-Contreras AE; Méndez-Díaz M; Prospéro-García O Brain Res; 2019 Dec; 1725():146485. PubMed ID: 31568767 [TBL] [Abstract][Full Text] [Related]
12. Repeated amphetamine administration induces Fos in prefrontal cortical neurons that project to the lateral hypothalamus but not the nucleus accumbens or basolateral amygdala. Morshedi MM; Meredith GE Psychopharmacology (Berl); 2008 Apr; 197(2):179-89. PubMed ID: 18080115 [TBL] [Abstract][Full Text] [Related]
13. Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus. Zhang J; Wang N; Chen B; Wang Y; He J; Cai X; Zhang H; Wei S; Li S Neurosci Lett; 2016 Sep; 630():70-76. PubMed ID: 27461790 [TBL] [Abstract][Full Text] [Related]
14. Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and d-Amphetamine Cross-Sensitization following Sex Abstinence. Beloate LN; Omrani A; Adan RA; Webb IC; Coolen LM J Neurosci; 2016 Sep; 36(38):9949-61. PubMed ID: 27656032 [TBL] [Abstract][Full Text] [Related]
15. GPR55 activation prevents amphetamine-induced conditioned place preference and decrease the amphetamine-stimulated inflammatory response in the ventral hippocampus in male rats. Sánchez-Zavaleta R; Segovia J; Ruiz-Contreras AE; Herrera-Solís A; Méndez-Díaz M; de la Mora MP; Prospéro-García OE Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110636. PubMed ID: 36099968 [TBL] [Abstract][Full Text] [Related]
16. Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference. Karimi S; Azizi P; Shamsizadeh A; Haghparast A Behav Brain Res; 2013 Jun; 247():125-31. PubMed ID: 23523958 [TBL] [Abstract][Full Text] [Related]
17. Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids. Covey DP; Bunner KD; Schuweiler DR; Cheer JF; Garris PA Eur J Neurosci; 2016 Jun; 43(12):1661-73. PubMed ID: 27038339 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates. Ahmad T; Laviolette SR Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Budygin EA; Brodie MS; Sotnikova TD; Mateo Y; John CE; Cyr M; Gainetdinov RR; Jones SR Proc Natl Acad Sci U S A; 2004 May; 101(20):7781-6. PubMed ID: 15136721 [TBL] [Abstract][Full Text] [Related]
20. Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation. Kleijn J; Wiskerke J; Cremers TI; Schoffelmeer AN; Westerink BH; Pattij T Neurochem Int; 2012 Jun; 60(8):791-8. PubMed ID: 22426202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]